News

Pliant Therapeutics Prepares for Major Respiratory Congress

Pliant Therapeutics Prepares for Major Respiratory Congress

Pliant Therapeutics Announces Upcoming Presentations

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a pioneer in developing innovative therapies for fibrotic diseases, has revealed plans for four important presentations at the European Respiratory Society (ERS) International Congress 2024. This congress will take place in Vienna and will highlight cutting-edge research in respiratory health and treatment alternatives.

Presentation Details

Late Breaker – Oral and ePoster Presentations

The first presentation will delve into the antifibrotic effects of bexotegrast, a dual ?V?6/?V?1 integrin inhibitor. Dr. Martin Decaris from Pliant Therapeutics will present this study, which evaluates the impact of bexotegrast using precision cut-lung slices obtained from non-IPF interstitial lung disease explants. This session is set for September 8 and will provide new insights into sarcoidosis.

Later Breaker – Oral and ePoster Presentations

Another intriguing presentation will examine the effects of bexotegrast on type 1 collagen deposition in patients with idiopathic pulmonary fibrosis (IPF) after 12 weeks of treatment. Dr. Sydney B. Montesi from Massachusetts General Hospital will share this vital research during a session focused on advancements in clinical practice for rare interstitial diseases.

Safety and Tolerability of Bexotegrast

Oral and Poster Presentations

Pliant Therapeutics will also present findings from Phase 2 trials assessing the safety and tolerability of bexotegrast in patients with IPF and primary sclerosing cholangitis (PSC). This presentation, led by Dr. Gregory Cosgrove from the company, is scheduled for September 9 and will discuss innovative management strategies that could transform treatment for pulmonary fibrosis.

Poster Presentation on Biomarkers

Additionally, a poster presentation will focus on a post-hoc biomarker analysis involving IPF participants who received bexotegrast over a 12-week period. Dr. Martin Decaris will share insights from this analysis during a session on the pathogenesis of pulmonary fibrosis and serum biomarkers on September 10.

About Pliant Therapeutics, Inc.

Pliant Therapeutics is committed to discovering and developing treatments for fibrotic diseases. Its leading product candidate, bexotegrast (PLN-74809), aims to offer groundbreaking solutions for conditions like IPF and PSC. The company has received Fast Track Designation and Orphan Drug Designation from the U.S. FDA for these conditions. Furthermore, Pliant has launched the BEACON-IPF trial, a crucial Phase 2b/3 study investigating the efficacy of bexotegrast.

In addition to these advancements, Pliant is also advancing PLN-101095, a new small molecule targeting solid tumors, and has obtained regulatory approval for a Phase 1 study of PLN-101325, which focuses on muscular dystrophies.

Contact Information

For further details, please visit Pliant Therapeutics' website. For inquiries from investors and the media, please reach out to Christopher Keenan, Vice President of Investor Relations and Corporate Communications at Pliant Therapeutics, Inc. via email at ir@pliantrx.com.

Frequently Asked Questions

What is the focus of the upcoming presentations by Pliant Therapeutics?

The presentations will concentrate on innovative research regarding the antifibrotic activity of bexotegrast, a treatment for fibrotic diseases.

When will the European Respiratory Society International Congress take place?

The congress is scheduled to occur from September 7 to September 11, 2024.

Where can I find more information about Pliant Therapeutics?

You can find additional information on Pliant Therapeutics' official website.

What is bexotegrast?

Bexotegrast is Pliant's primary product candidate, designed as a dual selective inhibitor targeting integrins associated with fibrotic diseases.

Who should contact Pliant Therapeutics for investor inquiries?

Investor inquiries should be directed to Christopher Keenan, Vice President of Investor Relations and Corporate Communications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Small Business Insurance Is a Costly Blind Spot Today

Updated Category News Views 131

A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...

Continue Reading
Ajman Media Forum Puts Trust Ahead of AI Speed in 2026

Updated Category News Views 199

Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...

Continue Reading
Caregiver Strategy Puts a Hard Truth on the Table Today

Updated Category News Views 57

Sixty-three million people carrying care responsibilities is not a side issue; it is a national load-bearing wall. The 2026 National Strategy to Support Family Caregivers arrives with that reality plainly in view, and frankly, it is overdue for the country to treat family care as core infrastructure rather than a private household problem somebody is expected to absorb...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 112

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
UnitedHealth’s CMS Audit Shock Puts Disclosures Under Lens

Updated Category News Views 98

Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...

Continue Reading
Bella Rio's Proposed Preferred B Share Giveaway Plan

Updated Category News Views 46

A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....

Continue Reading
Ampace Targets AI Data Centre UPS Safety Needs in Paris

Updated Category News Views 84

Backup power gets interesting only after the grid has disappointed everybody. At Data Centre World Paris 2026, Ampace put its attention on that ugly, split-second handoff: utility power drops, a UPS has to catch the load immediately, and nobody operating an AI data centre gets to shrug if it does not. A Narrow Job With Brutal Consequences The company showcased its PU200...

Continue Reading
Dutch Solar Homes Face a 2027 Net Metering Reset Ahead

Updated Category News Views 111

A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 91

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 175

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada Nickel Secures EDC Interest for $500 Million Financing

Updated Category News Views 137

Canada Nickel's Significant Financing Achievement Canada Nickel Company Inc. is excited to share a major milestone in its efforts to secure financing for the Crawford Nickel Sulphide Project. The company has received a Letter of Interest (LOI) from Export Development Canada (EDC), indicating its intention to offer up to US$500 million in long-term debt financing for the...

Continue Reading
BlackRock Expands Offerings with New ETF Share Class Approval

Updated Category News Views 202

BlackRock Pursues SEC Approval for ETF Share Classes BlackRock Inc (NYSE: BLK) is making headlines as it has formally applied to the U.S. Securities and Exchange Commission (SEC) for a ruling that would allow the establishment of exchange-traded fund (ETF) share classes linked to its existing mutual funds. This significant move positions BlackRock as the largest firm...

Continue Reading
Profusa Unveils Innovative AI Portal for Continuous Biochemistry Monitoring

Updated Category News Views 133

Profusa Introduces AI-Powered Insight Portal for Biomarker Monitoring Profusa, a pioneering company in digital health technology, is transforming how healthcare providers monitor patient biochemistry through an innovative AI-driven insight portal. This advanced portal will enhance continuous biomarker tracking, utilizing cutting-edge technology to provide clinical...

Continue Reading
Investigation Launch for Pliant Therapeutics Investors: What to Know

Updated Category News Views 192

Investigation of Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. (NASDAQ: PLRX) is currently under scrutiny as investors seek clarity on potential securities law violations. This investigation presents an opportunity for shareholders who believe they have been misled regarding their investments. Shareholders are encouraged to come forward to ensure their rights are...

Continue Reading
Fish Window Cleaning's New Headquarters: A Step Forward in Growth

Updated Category News Views 2161

Fish Window Cleaning Unveils New Corporate Headquarters Fish Window Cleaning Services is excited to announce the grand opening of its brand-new corporate headquarters, a facility that signifies an important milestone in its growth and operational capabilities. Located at 217 Chesterfield Towne Centre, this expansive 12,500-square-foot space is intended to serve as the...

Continue Reading